OPEN END TURBO LONG - QUEST DIAGNOSTICS | Real-time Bid/Ask 09:41:28 23/05/2024 BST | ||
| 3.59 EUR / 3.64 EUR | +0.14% |
|
| Current month | +4.94% | ||
| 1 month | +33.70% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 3.62 | +0.28% |
| 22/05/24 | 3.61 | -4.24% |
| 21/05/24 | 3.77 | -1.05% |
| 20/05/24 | 3.81 | -0.78% |
| 17/05/24 | 3.84 | +4.92% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 08:23 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | ME72Z4 |
| ISIN | DE000ME72Z46 |
| Date issued | 17/01/2024 |
| Strike | 103 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.28 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.93 € |
|---|---|
| Lowest since issue | 1.99 € |
| Spread | 0.05 € |
| Spread % | 1.37% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.9
USD
Average target price
146.8
USD
Spread / Average Target
+3.48%
- Stock Market
- Certificates
- Certificat
